AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider.

Alchemab’s new CEO is the company’s co-founder and hitherto CSO, Jane Osbourn.

The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...

FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...

MTS Health Partners ("MTS") announced today that healthcare investment banker Aaron Schwimmer has joined their global life sciences practice as a Partner based in New York.

AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider. FluMist ...

The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug ...

FRIDAY, Sept. 20, 2024 (HealthDay News) -- The days of waiting for a flu shot at your doctor's office or local pharmacy may ...

The FDA has approved the game-changing first flu vaccine spray that can be self-administered!On Friday, September 20, the ...

The US Food and Drug Administration has approved first self- or caregiver-administered flu vaccine FluMist.FluMist is ...

Through a third-party pharmacy, people interested in the self or caregiver option will complete a screening and eligibility ...